This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ajou University Industry-Academic Cooperation Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Beomyong Shin: Innovator in Tissue Regeneration
Introduction
Beomyong Shin is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of tissue regeneration, particularly through his innovative patent related to chronic tympanic perforation treatment.
Latest Patents
Beomyong Shin holds a patent for a "PCL patch tissue regeneration scaffold and method for manufacturing same." This patent discloses a method of treating chronic tympanic perforation using a PCL patch tissue regeneration scaffold. The process involves preparing a solution by adding polycaprolactone (PCL) and an acid to an organic solvent. An electrospinning solution is then created by adding a growth factor to the solution and stirring. The nanofibers are collected in a spindle shape on a collector by connecting the electrospinning solution to a syringe pump and operating the electrospinning device. Finally, the PCL patch tissue regeneration scaffold is administered to a subject. Beomyong Shin has 1 patent to his name.
Career Highlights
Beomyong Shin is affiliated with the Ajou University Industry-Academic Cooperation Foundation, where he continues to advance research in tissue engineering and regenerative medicine. His work has garnered attention for its potential applications in medical treatments.
Collaborations
He has collaborated with notable colleagues, including Yun-Hoon Choung and Jong Hoon Chung, contributing to various research initiatives and projects in the field.
Conclusion
Beomyong Shin's innovative work in tissue regeneration exemplifies the impact of research and development in medical science. His contributions are paving the way for advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile